Ledger.Open graph →
SEC Form D · filed December 3, 2025

ADIAL PHARMACEUTICALS, INC

Offering
$4.3M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
GLEN ALLEN, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Kevin W. Schuyler, Cfa · Glen Allen, VADirectorRobertson H. Gilliland · Glen Allen, VADirectorTony W. Goodman · Glen Allen, VAExec · DirectorCary J. Claiborne · Glen Allen, VAExec · DirectorVinay J. Shah · Glen Allen, VAExecJames K. Anderson · Glen Allen, VADirectorJames W. Newman, Jr · Glen Allen, VADirectorCary J. Claiborne · Glen Allen, VAExec · DirectorJames W. Newman, Jr · Glen Allen, VADirectorKevin W. Schuyler, Cfa · Glen Allen, VADirectorVinay J. Shah · Glen Allen, VAExecJames K. Anderson · Glen Allen, VADirectorTony W. Goodman · Glen Allen, VAExec · DirectorRobertson H. Gilliland · Glen Allen, VADirectorChris T. Todd · Chicago, ILExecBrittany T. Smith · Chicago, ILDirectorGail T. Mcgiffin · Chicago, ILExec · DirectorJoseph T. Ghobrial · Chicago, ILExec · DirectorGraham T. Blackwell · Chicago, ILDirectorRichard T. Cohan · Chicago, ILDirectorWilliam T. Rhodes · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗